What are the treatment options for migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Treatment Options

For acute episodic migraine treatment, start with NSAIDs or acetaminophen, and if inadequate relief occurs, add a triptan (combination therapy of triptan plus NSAID or acetaminophen provides superior relief compared to monotherapy). 1

First-Line Treatment Options

For Mild to Moderate Migraines:

  • NSAIDs (first choice):

    • Ibuprofen 400-800mg
    • Naproxen 500mg
    • Aspirin 900mg
    • Diclofenac potassium 1
  • Acetaminophen:

    • Less effective as monotherapy but useful when NSAIDs are contraindicated 1, 2
    • More effective when combined with aspirin and caffeine 1

For Moderate to Severe Migraines:

  • Triptans (when NSAIDs provide inadequate relief):

    • Sumatriptan 25mg, 50mg, or 100mg
    • Rizatriptan
    • Zolmitriptan
    • Naratriptan
    • Almotriptan
    • Eletriptan
    • Frovatriptan 1, 3
  • Combination therapy (most effective approach):

    • Triptan + NSAID (e.g., sumatriptan + naproxen)
    • Triptan + acetaminophen (when NSAIDs contraindicated) 1

Second-Line and Alternative Options

For Patients with Inadequate Response to First-Line Treatments:

  • CGRP antagonists (gepants):

    • Rimegepant
    • Ubrogepant
    • Zavegepant 1, 2
  • Ergot alkaloids:

    • Dihydroergotamine (DHE) 1
  • Ditan:

    • Lasmiditan (last resort when other options fail) 1, 2

For Migraine with Significant Nausea/Vomiting:

  • Non-oral routes of administration:
    • Sumatriptan subcutaneous injection (6mg) - fastest onset of action 2, 3
    • Sumatriptan intranasal spray
    • DHE nasal spray
    • Antiemetics (metoclopramide, prochlorperazine) 1, 2

Treatment Algorithm

  1. Assess migraine severity:

    • Mild to moderate: Start with NSAID or acetaminophen
    • Moderate to severe: Consider triptan or combination therapy immediately
  2. If initial treatment fails:

    • Add a triptan to NSAID/acetaminophen
    • Try different triptan if first one ineffective
    • Consider non-oral route if nausea/vomiting present
  3. For refractory cases:

    • Try CGRP antagonists or DHE
    • Consider lasmiditan as last resort
    • Evaluate for preventive therapy if attacks are frequent

Important Clinical Considerations

  • Timing matters: Treat early in the attack for better efficacy 1, 4
  • Avoid overuse: Medication overuse headache can occur with frequent use (≥15 days/month for NSAIDs; ≥10 days/month for triptans) 1
  • Never use opioids or butalbital for migraine treatment due to dependency risk, rebound headaches, and loss of efficacy 1, 2
  • Consider preventive therapy if migraine occurs frequently or treatment doesn't provide adequate response 1

Evidence Quality and Efficacy

  • Sumatriptan 100mg shows superior efficacy with NNT of 4.7 for pain-free at 2 hours compared to placebo 4
  • Combination therapy of triptan + NSAID/acetaminophen shows greater net benefit than monotherapy 1
  • Early treatment during mild pain phase gives significantly better outcomes than treating established attacks 4
  • Subcutaneous sumatriptan has faster onset (1 hour) with higher response rates (70-84%) compared to oral formulation (50-67% at 2 hours) 5

Common Pitfalls to Avoid

  • Not addressing nausea as a component of migraine
  • Overusing acute medications leading to medication overuse headache
  • Using opioids or butalbital-containing medications
  • Not considering non-oral routes when needed for patients with significant nausea/vomiting
  • Failing to start treatment early in the attack

By following this evidence-based approach to migraine treatment, focusing on NSAIDs/acetaminophen for mild attacks and adding triptans for moderate-severe attacks, patients can achieve better control of their migraine symptoms and improved quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Migraine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sumatriptan (oral route of administration) for acute migraine attacks in adults.

The Cochrane database of systematic reviews, 2012

Research

Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.

Cephalalgia : an international journal of headache, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.